Neostigmine methylsulfate/Glycopyrrolate - Slayback Pharma
Alternative Names: neostigmine methylsulfate and glycopyrrolate injection; Neostigmine methylsulfate/Glycopyrrolate; PrevduoLatest Information Update: 27 Apr 2024
At a glance
- Originator Endo International; Slayback Pharma
- Developer Endo, Inc.
- Class Antiasthmatics; Antiglaucomas; Antispasmodics; Antiulcers; Pyrrolidines; Quaternary ammonium compounds; Skin disorder therapies; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neuromuscular blockade